This is the authors' abstract. We don't add key points for this paper.
Staphylococci, with the leading species Staphylococcus aureus and Staphylococcus epidermidis, are the most frequent causes of infections on indwelling medical devices. The biofilm phenotype that those bacteria adopt during device-associated infection facilitates increased resistance to antibiotics and host immune defenses. This review presents and discusses the molecular mechanisms contributing to staphylococcal biofilm development and their in-vivo importance. Furthermore, it summarizes current strategies for the development of therapeutics against staphylococcal biofilm-associated infection.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Michaël Otto (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: